
Emily Larnard
Associate Program Director · Beth Israel Deaconess Medical Center
Credentials: · · · · ·
History
Research
Clinical Cancer Research · 2016 · 1,124 citations
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Science · 2014 · 609 citations
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Nature Communications · 2015 · 553 citations
- JE
3 papers

3 papers
- MM
3 papers

2 papers

2 papers

2 papers

2 papers

2 papers · 2 as a fellow



